modified rituximab (Ben-Gurion University Of The Negev)

N/A

Report date: 2025/03/20 16:07:49

Base Information

Drug Namemodified rituximab (Ben-Gurion University Of The Negev)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody

Mechanisms of ActionImmunomodulatorsNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBen-Gurion University of the Negev

China Registration ClassN/A

Develop Information

Active CompaniesBen-Gurion University of the Negev

Inactive CompaniesN/A

Active IndicationsAmyotrophic Lateral Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A